Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P5QI
|
||||
Former ID |
DNC010087
|
||||
Drug Name |
2-Hydroxymethyl-3-hydroxymorphinan
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530529] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H25NO2
|
||||
Canonical SMILES |
CN1CCC23CCCCC2C1CC4=CC(=C(C=C34)O)CO
|
||||
InChI |
1S/C18H25NO2/c1-19-7-6-18-5-3-2-4-14(18)16(19)9-12-8-13(11-20)17(21)10-15(12)18/h8,10,14,16,20-21H,2-7,9,11H2,1H3/t14-,16+,18+/m0/s1
|
||||
InChIKey |
BPBSRBFSNMZXSP-YXJHDRRASA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | |
Delta-type opioid receptor | Target Info | Inhibitor | [530529] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.